Veterinary Drug Market
Veterinary Drug Market Size, Share & Trends Analysis Report, By Product Type (Anti-infectives, Anti-Inflammatory, Parasiticides, Vaccines, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce/Online Pharmacies, Farm & Agricultural Supply Stores), Forecast Period (2026–2035)
Industry Overview
Veterinary drug market is valued at $50.0 billion in 2025 and is projected to reach $85.0 billion by 2035, growing at a CAGR of 6.3% during 2026–2035. The market is witnessing strong growth due to increasing global demand for animal protein, rising pet ownership, and growing awareness of zoonotic disease prevention. According to the Food and Agriculture Organization, global meat production is expected to exceed 370 million tonnes by 2030, reflecting significant expansion in livestock farming, which directly drives veterinary drug consumption. Among product types, Vaccines represent the fastest-growing segment due to increasing emphasis on preventive healthcare over curative treatments. The shift toward biologics is supported by regulatory restrictions on antibiotic usage in livestock and growing awareness regarding antimicrobial resistance. Major end-use sectors include livestock farming (cattle, poultry, swine), companion animal healthcare, and aquaculture. Increasing investments in biologics and vaccines, along with regulatory pressure to reduce antibiotic usage, are further shaping industry trends and accelerating market growth globally.
Rising Livestock Production and Zoonotic Disease Prevention Drives Market Growth
The growth of the veterinary drug market is strongly driven by increasing livestock production and the need to ensure food safety. The Organization for Economic Co-operation and Development and FAO jointly estimate that global demand for animal protein will grow significantly by 2030, supported by population growth and rising incomes. This has led to increased use of veterinary drugs such as anti-infectives and vaccines to maintain animal health and productivity. Furthermore, zoonotic diseases remain a major global concern. The WHO highlights that 75% of emerging infectious diseases are zoonotic, reinforcing the need for preventive veterinary healthcare. Companies such as Zoetis Inc. and Merck & Co., Inc. are investing heavily in vaccine development and biologics innovation for some years to address these challenges. Increased government vaccination programs and disease surveillance initiatives are further boosting market demand.
Regulatory Restrictions and Antibiotic Resistance Pose Challenges
Despite strong growth, the veterinary drug market faces challenges related to regulatory restrictions and antimicrobial resistance. The World Health Organization has emphasized the global threat of antimicrobial resistance (AMR), urging countries to reduce the use of antibiotics in livestock. This has led to stricter regulations, particularly in Europe and North America, limiting the use of certain anti-infectives. Additionally, high R&D costs and complex approval processes create barriers for new product development. Supply chain disruptions, especially for active pharmaceutical ingredients (APIs), also impact production. In response, companies such as Elanco Animal Health Incorporated and Boehringer Ingelheim International GmbH are focusing on alternative solutions, including biologics, vaccines, and non-antibiotic therapies. Additionally, innovation in preventive care, biologics, and advanced animal health technologies is emerging as a key strategy to overcome these challenges.
Market Segmentation
- Based on the product type, the market is segmented into anti-infectives, anti - inflammatory, parasiticides, vaccines, and others.
- Based on the route of administration, the market is segmented into oral, injectable, topical, and others.
- Based on the distribution channel, the market is segmented into veterinary hospitals & clinics, retail pharmacies, e-commerce / online pharmacies, and farm & agricultural supply stores.
Parasiticides Segment Leads the Market
The parasiticides segment dominates the veterinary drug market due to the high prevalence of parasitic infections in both livestock and companion animals. Fleas, ticks, and internal parasites significantly impact animal productivity and health, driving consistent demand for parasiticides. The widespread adoption of preventive treatments, especially in developed markets, further strengthens segment dominance.
Vaccines Segment to Record Strong Growth
The Vaccines segment is expected to witness the fastest growth during the forecast period due to increasing focus on preventive healthcare. Rising concerns over zoonotic diseases and regulatory restrictions on antibiotics are accelerating vaccine adoption. Technological advancements in recombinant vaccines and immunotherapies are driving innovation. Companies like Ceva Santé Animale are expanding vaccine portfolios, particularly in poultry and livestock segments. Increasing investments in R&D and government-led vaccination programs are further supporting segment growth.
Regional Outlook
The global veterinary drug market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).
United States Leads the Market
The United States continues to dominate the veterinary drug market in 2026 due to its highly advanced animal healthcare ecosystem and strong regulatory framework led by the U.S. Food and Drug Administration. The FDA reported increasing approvals of veterinary biologics and drugs, reflecting rising innovation in animal health. Additionally, according to the American Veterinary Medical Association, The population of pet dogs to 87.3 million in 2025, driving demand for companion animal therapeutics. High expenditure on pet healthcare and insurance penetration further strengthens the market. The country also benefits from strong R&D investments by leading players and rapid adoption of advanced treatments such as vaccines and parasiticides.
China to Record Strong Growth
China is expected to witness robust growth in the veterinary drug market in 2026, driven by rapid expansion in livestock production and rising protein consumption. With continuous government support for food security, the country is investing heavily in modernizing animal healthcare infrastructure and disease prevention systems. Additionally, increasing concerns over zoonotic diseases and stricter regulations on animal health are boosting demand for vaccines and anti-infectives. Growing domestic manufacturing capabilities and export activities further enhance China’s market growth potential.
Competitive Landscape
The veterinary drug market is highly competitive, companies such as Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Merck & Co., Inc., and Zoetis Inc. dominate the market through strong product portfolios and global distribution networks. Continuous investment in biologics, vaccines, and digital veterinary solutions is shaping competitive dynamics.
Recent Developments
- In November 2025,
- In March 2025, Elanco Animal Health Incorporated entered a research agreement to explore novel therapies for chronic kidney disease and life extension in pets. The collaboration aims to develop next-generation veterinary therapeutics, supporting long-term innovation in animal health.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global veterinary drug market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Veterinary Drug Market Sales Analysis – Product Type | Route of Administration | Distribution Channel ($ Million)
- Veterinary Drug Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Veterinary Drug Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Veterinary Drug Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Veterinary Drug Market: Impact Analysis
- Market Opportunities
- Opportunities For Veterinary Drug Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Veterinary Drug Market Revenue and Share by Manufacturers
- Veterinary Drug Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Boehringer Ingelheim International GmbH
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Ceva Santé Animale
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Elanco Animal Health Incorporated
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck & Co., Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Zoetis Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Boehringer Ingelheim International GmbH
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Veterinary Drug Market Sales Analysis By Product Type ($ Million)
- Anti-infectives
- Anti-Inflammatory
- Parasiticides
- Vaccines
- Others
- Veterinary Drug Market Sales Analysis By Route of Administration ($ Million)
- Oral
- Injectable
- Topical
- Others
- Veterinary Drug Market Sales Analysis By Distribution Channel ($ Million)
- Veterinary Hospitals & Clinics
- Retail Pharmacies
- E-commerce / Online Pharmacies
- Farm & Agricultural Supply Stores
- Regional Analysis
- North American Veterinary Drug Market Sales Analysis – Product Type | Route of Administration | Distribution Channel ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Veterinary Drug Market Sales Analysis – Product Type | Route of Administration | Distribution Channel ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Veterinary Drug Market Sales Analysis – Product Type | Route of Administration | Distribution Channel ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Veterinary Drug Market Sales Analysis – Product Type | Route of Administration | Distribution Channel ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Ashish Life Science Pvt. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biogénesis Bagó
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim International GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ceva Santé Animale
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chanelle Pharma Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dechra Pharmaceuticals PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ECO Animal Health Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Elanco Animal Health Incorporated
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hester Biosciences Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HIPRA (Laboratorios Hipra, S.A.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Huvepharma EOOD
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Indian Immunologicals Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Intas Pharmaceuticals Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kyoritsu Seiyaku Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Neogen Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Norbrook Laboratories Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ourofino
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Phibro Animal Health Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sequent Scientific Limited (Alivira Animal Health limited)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vaxxinova International BV
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vetoquinol S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Virbac S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zoetis Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zydus Lifesciences Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ashish Life Science Pvt. Ltd.
1. Global Veterinary Drug Market Research And Analysis By Product Type, 2025-2035 ($ Million)
2. Global Veterinary Drug Anti-Infectives Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Veterinary Drug Anti-Inflammatory Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Veterinary Drug Parasiticides Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Veterinary Drug Vaccines Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Veterinary Drug Others Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Veterinary Drug Market Research and Analysis by Route of Administration, 2025–2035 ($ Million)
8. Global Veterinary Drug Oral Market Research And Analysis By Region, 2025-2035 ($ Million)
9. Global Veterinary Drug Injectable Market Research And Analysis By Region, 2025-2035 ($ Million)
10. Global Veterinary Drug Topical Market Research And Analysis By Region, 2025-2035 ($ Million)
11. Global Veterinary Drug Other Market Research And Analysis By Region, 2025-2035 ($ Million)
12. Global Veterinary Drug Market Research and Analysis by Route of Administration, 2025–2035 ($ Million)
13. Global Veterinary Drug For Veterinary Hospitals & Clinics Market Research And Analysis By Region, 2025-2035 ($ Million)
14. Global Veterinary Drug For Retail Pharmacies Market Research And Analysis By Region, 2025-2035 ($ Million)
15. Global Veterinary Drug For E-commerce / Online Pharmacies Market Research And Analysis By Region, 2025-2035 ($ Million)
16. Global Veterinary Drug For Farm & Agricultural Supply Stores Market Research And Analysis By Region, 2025-2035 ($ Million)
17. Global Veterinary Drug Market Research And Analysis By Region, 2025-2035 ($ Million)
18. North American Veterinary Drug Market Research And Analysis By Country, 2025-2035 ($ Million)
19. North American Veterinary Drug Market Research And Analysis By Product Type, 2025-2035 ($ Million)
20. North American Veterinary Drug Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
21. North American Veterinary Drug Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
22. European Veterinary Drug Market Research And Analysis By Country, 2025-2035 ($ Million)
23. European Veterinary Drug Market Research And Analysis By Product Type, 2025-2035 ($ Million)
24. European Veterinary Drug Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
25. European Veterinary Drug Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
26. Asia-Pacific Veterinary Drug Market Research And Analysis By Country, 2025-2035 ($ Million)
27. Asia-Pacific Veterinary Drug Market Research And Analysis By Product Type, 2025-2035 ($ Million)
28. Asia-Pacific Veterinary Drug Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
29. Asia-Pacific Veterinary Drug Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
30. Rest Of The World Veterinary Drug Market Research And Analysis By Country, 2025-2035 ($ Million)
31. Rest Of The World Veterinary Drug Market Research And Analysis By Product Type, 2025-2035 ($ Million)
32. Rest Of The World Veterinary Drug Market Research And Analysis By Route of Administration, 2025-2035 ($ Million)
33. Rest Of The World Veterinary Drug Market Research And Analysis By Distribution Channel, 2025-2035 ($ Million)
1. Global Veterinary Drug Market Research and Analysis By Product Type, 2025 Vs 2035 (%)
2. Global Veterinary Drug Anti-infectives Market Research and Analysis by Region, 2025 Vs 2035 (%)
3. Global Veterinary Drug Anti-Inflammatory Market Research and Analysis by Region, 2025 Vs 2035 (%)
4. Global Veterinary Drug Parasiticides Market Research and Analysis by Region, 2025 Vs 2035 (%)
5. Global Veterinary Drug Vaccines Market Research and Analysis by Region, 2025 Vs 2035 (%)
6. Global Veterinary Drug Others Market Research and Analysis by Region, 2025 Vs 2035 (%)
7. Global Veterinary Drug Market Research and Analysis by Route of Administration, 2025 Vs 2035 (%)
8. Global Veterinary Drug Oral Market Research and Analysis by Region, 2025 Vs 2035 (%)
9. Global Veterinary Drug Injectable Market Research and Analysis by Region, 2025 Vs 2035 (%)
10. Global Veterinary Drug Topical Market Research and Analysis by Region, 2025 Vs 2035 (%)
11. Global Veterinary Drug Others Market Research and Analysis by Region, 2025 Vs 2035 (%)
12. Global Veterinary Drug Market Research and Analysis by Distribution Channel, 2025 Vs 2035 (%)
13. Global Veterinary Drug For Veterinary Hospitals & Clinics Market Research and Analysis by Region, 2025 Vs 2035 (%)
14. Global Veterinary Drug For Retail Pharmacies Market Research and Analysis by Region, 2025 Vs 2035 (%)
15. Global Veterinary Drug For E-commerce / Online Pharmacies Market Research and Analysis by Region, 2025 Vs 2035 (%)
16. Global Veterinary Drug For Farm & Agricultural Supply Stores Market Research and Analysis by Region, 2025 Vs 2035 (%)
17. Global Veterinary Drug Market Research And Analysis By Region, 2025 Vs 2035 (%)
18. US Veterinary Drug Market Size, 2025-2035 ($ Million)
19. Canada Veterinary Drug Market Size, 2025-2035 ($ Million)
20. UK Veterinary Drug Market Size, 2025-2035 ($ Million)
21. France Veterinary Drug Market Size, 2025-2035 ($ Million)
22. Germany Veterinary Drug Market Size, 2025-2035 ($ Million)
23. Italy Veterinary Drug Market Size, 2025-2035 ($ Million)
24. Spain Veterinary Drug Market Size, 2025-2035 ($ Million)
25. Russia Veterinary Drug Market Size, 2025-2035 ($ Million)
26. Rest Of Europe Veterinary Drug Market Size, 2025-2035 ($ Million)
27. India Veterinary Drug Market Size, 2025-2035 ($ Million)
28. China Veterinary Drug Market Size, 2025-2035 ($ Million)
29. Japan Veterinary Drug Market Size, 2025-2035 ($ Million)
30. South Korea Veterinary Drug Market Size, 2025-2035 ($ Million)
31. Australia And New Zealand Veterinary Drug Market Size, 2025-2035 ($ Million)
32. ASEAN Economies Veterinary Drug Market Size, 2025-2035 ($ Million)
33. Rest Of Asia-Pacific Veterinary Drug Market Size, 2025-2035 ($ Million)
34. Latin America Veterinary Drug Market Size, 2025-2035 ($ Million)
35. Middle East And Africa Veterinary Drug Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
